Sep 2026
Innovations in Nanotechnology-based Drug Delivery for Ischemic Stroke.
Endogenous cell-mediated transport (CMT) represents a superior strategy for traversing the blood-brain barrier in ischemic stroke, enabling the attainment of therapeutic drug concentrations at the lesion site while simultaneously mitigating systemic toxicity.
S. Nirala, Shu-Yu Wu, Ahmed Hammad et al.
· Current Neuropharmacology · 0 citations